24.09
-0.27 (-1.11%)
| Penutupan Terdahulu | 24.36 |
| Buka | 24.30 |
| Jumlah Dagangan | 1,183,353 |
| Purata Dagangan (3B) | 1,629,354 |
| Modal Pasaran | 1,370,947,840 |
| Harga / Jualan (P/S) | 4.39 |
| Harga / Buku (P/B) | 3.79 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Apr 2026 |
| Margin Keuntungan | -36.20% |
| Margin Operasi (TTM) | -39.67% |
| EPS Cair (TTM) | -1.69 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 55.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 21.02% |
| Nisbah Semasa (MRQ) | 8.95 |
| Aliran Tunai Operasi (OCF TTM) | -83.91 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -58.77 M |
| Pulangan Atas Aset (ROA TTM) | -13.36% |
| Pulangan Atas Ekuiti (ROE TTM) | -27.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | PROCEPT BioRobotics Corporation | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.13 |
|
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 4.22% |
| % Dimiliki oleh Institusi | 93.06% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 34.00 (Wells Fargo, 41.14%) | Beli |
| 34.00 (TD Cowen, 41.14%) | Beli | |
| Median | 30.00 (24.53%) | |
| Rendah | 20.00 (B of A Securities, -16.98%) | Jual |
| Purata | 29.43 (22.17%) | |
| Jumlah | 5 Beli, 1 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 24.04 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Baird | 06 Mar 2026 | 30.00 (24.53%) | Pegang | 24.22 |
| Truist Securities | 02 Mar 2026 | 30.00 (24.53%) | Beli | 25.90 |
| B of A Securities | 26 Feb 2026 | 20.00 (-16.98%) | Jual | 23.63 |
| Leerink Partners | 26 Feb 2026 | 30.00 (24.53%) | Beli | 23.63 |
| Piper Sandler | 26 Feb 2026 | 28.00 (16.23%) | Beli | 23.63 |
| TD Cowen | 26 Feb 2026 | 34.00 (41.14%) | Beli | 23.63 |
| Wells Fargo | 26 Feb 2026 | 34.00 (41.14%) | Beli | 23.63 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 04 Feb 2026 | Pengumuman | PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |